Ganli Pharmaceutical: Shareholders holding more than 5% of the company's shares have released a pledge of 700,000 shares.

Ganli Pharmaceuticals announced that its shareholder Xute Hongda completed the procedures for releasing the pledge of 700,000 shares of the company on January 20, 2026, representing 5.37% of the total shares held, 2.18% of the company's total share capital. After this release, Xute Hongda has pledged a total of 22.71 million shares of the company, accounting for 70.81% of its holdings and 3.80% of the company's total share capital. Controlling shareholder Gan Zhongru and Xute Hongda, controlled by him, collectively hold 39.80% of the company's shares, with pledged shares accounting for 9.55% of their holdings and 3.80% of the company's total share capital. Xute Hongda has good creditworthiness, the risk of share pledge is controllable, and it has no substantial impact on the company's operations.